fludarabine has been researched along with Histiocytosis, Non-Langerhans-Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caenazzo, L; Calore, E; Cesaro, S; De Silvestro, G; Destro, R; Gazzola, MV; Marson, P; Messina, C; Pillon, M; Varotto, S; Zanesco, L | 1 |
| Arizpe-Bravo, D; Garcés-Eisele, J; Ponce-de-León, S; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ; Sánchez-Sosa, S | 1 |
| Greene, V; Kanold, J; Schneider, P; Vannier, JP | 1 |
3 other study(ies) available for fludarabine and Histiocytosis, Non-Langerhans-Cell
| Article | Year |
|---|---|
Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Graft Survival; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Remission Induction; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2003 |
Tuberculosis-associated fatal hemophagocytic syndrome in a patient with lymphoma treated with fludarabine.
Topics: Adult; Antineoplastic Agents; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Tuberculosis; Vidarabine | 1998 |
Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Male; Remission Induction; Vidarabine | 2001 |